Interim results from AIR, an open-label, single arm, 36-week ph 2 trial of C21 in subjects with idiopathic pulmonary fibrosis

Autor: T Maher, C Ganslandt, R Batta, G Tornling, T Bengtsson, H Pophale, E Rosendahl
Rok vydání: 2022
Zdroj: 12.01 - Idiopathic interstitial pneumonias.
DOI: 10.1183/13993003.congress-2022.4402
Databáze: OpenAIRE